Capital markets : Equity
Corporate and M&A
Susan is a partner in Matheson's Corporate M&A Group, with a particular focus on public company transactional, advisory and corporate governance matters.
Susan advises clients on public M&A, redomiciliations and equity capital markets transactions, having particular expertise in advising US and other international clients on cross-border acquisitions of Irish companies, migrations, capital raisings and equity capital markets transactions (undertaken domestically and by Irish companies listed on US and other foreign exchanges).
As a founding member of the firm's Public Company Advisory and Corporate Governance Group, Susan counsels clients on the full range of corporate governance, compliance, securities laws and advisory matters that arise for listed Irish companies.
Prior to joining the Corporate M&A Group, Susan worked in Matheson’s Corporate Restructuring and Insolvency Department.
Susan has advised:
Horizon Therapeutics plc (a global biotech company) on its US$27.5 billion acquisition by Amgen Inc. by way of scheme of arrangement under the Irish Companies Act and pursuant to the Irish Takeover Rules;
Finnish registered MariaDB Corporation Ab on its business combination with NYSE-listed SPAC, Angel Pond Holdings Corporation;